<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixty-four patients with American Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (AMBL) treated at the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute were reviewed to determine the frequency and characteristics of central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) involvement </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with minimal or completely resected <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> never had <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease </plain></SENT>
<SENT sid="2" pm="."><plain>Of the 45 patients with more <z:e sem="disease" ids="C0849867" disease_type="Disease or Syndrome" abbrv="">extensive disease</z:e>, 15 had <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease: nine presented with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease, six of whom subsequently had recurrent <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease, and six developed <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease only at relapse </plain></SENT>
<SENT sid="3" pm="."><plain>There was a significant association between <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> and <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone-marrow disease</z:e> at presentation </plain></SENT>
<SENT sid="4" pm="."><plain>Therapy of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease consisted of short courses of intrathecal chemotherapy with <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Cranial irradiation was given only to patients with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> relapse </plain></SENT>
<SENT sid="6" pm="."><plain>There are six long-term survivors (LTS) who have been disease free for four to six years post chemotherapy </plain></SENT>
<SENT sid="7" pm="."><plain>Of these six LTS, three presented with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease, two experienced isolated <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> relapse, and one had <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease both at presentation and at relapse </plain></SENT>
<SENT sid="8" pm="."><plain>Three of the six LTS never received cranial irradiation </plain></SENT>
<SENT sid="9" pm="."><plain>It is concluded that <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement in AMBL can be effectively treated, and that long-term remission, which is probably cure, can be achieved </plain></SENT>
</text></document>